District chemotherapy centres to enhance accessibility
In a significant move aimed at bridging the gap between rural and urban healthcare delivery, the Karnataka government is rolling out(DCCC) across the state under a hub-and-spoke model. The initiative seeks to decentralise cancer care and improve accessibility, particularly for patients in remote areas.As per the latest report by the Indian Council of Medical Research–National Cancer Registry Programme (ICMR-NCRP 2023), Karnataka records nearly 70,000 new cancer cases annually. The most common types include breast cancer (18%), cervical cancer (14%), oral cancer (12%), lung cancer (8%), and colorectal cancer (6%). Alarmingly, the incidence rate of oral cancer in the state stands at 12 cases per one lakh population, surpassing the national average. Similarly, breast cancer incidence among women is 35 per lakh, and cervical cancer affects 15 per lakh women.However, access to chemotherapy remains a challenge. According to Health Department officials, nearly 60% of cancer patients in Karnataka are forced to travel over 100 km, often to major cities such as Bengaluru, Hubballi, or Mysuru, for chemotherapy sessions. This not only causes logistical strain but also leads to high dropout rates of up to 30%, as patients struggle with the costs and effort involved in repeated hospital visits.An official said that the DCCC project has been conceptualised to address these challenges and deliver equitable, cost-effective, and continuous cancer care at the district level. 'The model involves establishing district-level 'spoke'centres connected to tertiary 'hub' hospitals via Memorandums of Understanding (MoUs), allowing for shared resources, referrals, and training,' said the official.Under this framework, hub hospitals, which are tertiary cancer centres, will continue to provide advanced clinical services such as complex treatments, specialised diagnostics including PET-CT scans and molecular profiling, as well as training and telemedicine support. They will also monitor treatment quality and guide spokes in clinical decision-making.The spoke centres, or DCCCs, will focus on delivering outpatient chemotherapy to stable patients, particularly adjuvant and palliative chemotherapy. These centres will also conduct basic pre-treatment diagnostics, maintain a drug inventory, and provide essential support services such as pain management, counselling, and palliative care. Each unit will have a dedicated medical team, including a visiting medical oncologist, trained nurses, a physician, a pharmacist, and a counsellor.With treatment available within home districts, travel time and expenses will reduce drastically, significantly benefiting patients. The out-of-pocket expenditure is expected to decline by up to 40%, and the convenience of local treatment is likely to enhance adherence and reduce dropout rates.Additionally, the DCCCs are expected to help decongest tertiary care centres, allowing them to focus on complex cases. The district-level centres will also integrate with national screening programs like the National Programme for Prevention and Control of Non-Communicable Diseases (NPNCD) to ensure early detection and timely intervention.Each DCCC will function according to pre-approved treatment protocols aligned with the essential medicine list of the Suvarna Arogya Suraksha Trust (SAST). The performance of these centres will be closely monitored using key indicators such as patient turnout, treatment completion rates, adverse event tracking, and cost comparison with private sector benchmarks, said a Health Department official.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
United News of India
10 hours ago
- United News of India
Japanese Encephalitis reduced to single digit in UP, spread of AES also down
Lucknow, Aug 3 (UNI) Japanese Encephalitis, which was an epidemic in Purvanchal of Uttar Pradesh till 2017, has currently reduced to a single digit, according to UP health officials. The spread of Acute Encephalitis (AES), another form of JE, has also reduced, they added. Officials said due to the efforts being made by the government against the communicable diseases, Japanese Encephalitis is inching closer to eradication. For the last more than five decades, this disease was synonymous with death in Purvanchal. Every year thousands of children died prematurely. When Chief Minister Yogi Adityanath took over in 2017, he gave the eradication of the disease the form of a mass movement. For this, a coordination committee of 17 departments was formed by keeping the Health Department as the nodal agency. The 17 departments included Urban and rural development, panchayati raj, education department, Jal Jeevan Mission and others. Like every year, this time under the Communicable Disease Campaign which ran from July 1 to July 31 in the state, a cleanliness campaign along with awareness was run in JE and AES-affected districts of Gorakhpur, Kushinagar, Maharajganj, Deoria, Basti, Sant Kabir Nagar, Siddharth Nagar, Azamgarh and Mau. The result is that the scope of this disease has further reduced. According to state surveillance officer Dr Vikasendu Agarwal, this time from January till now, 137 cases of AES have been reported, but there has been no death. Last year 332 AES cases were reported. However, only 4 cases of JE have been reported this time. Last year, 18 such cases came to light. Similarly, this time only one case of Kala Azar has been found in the state, whereas 827 cases of dengue have been detected. Last year this figure was 451. Similarly, this time 129 cases of Chikungunya have been reported, whereas last year, the figure was 128. This time 7,419 cases of malaria have been reported. Last year this figure was 3,013. Regarding the increase in dengue cases, doctors say that it increases every third year. Therefore, there are chances of an uptick this time. Monsoon rain is also being cited as a reason behind malaria cases. UNI MBD PRS
News18
10 hours ago
- News18
Lung Cancer In Women: Why The Symptoms Are Often Missed Or Misdiagnosed
For women in India, lung cancer is often in plain sight but overlooked due to diagnostic and societal barriers Lung cancer is one of the most prevalent causes of cancer deaths among women glocally. In the United States, lung cancer surpassed breast cancer as the leading cause of cancer-related deaths among females since 1987. In India, lung cancer is also on the rise among women, emerging as a significant public health concern. According to the National Cancer Registry Programme (NCRP) data for 2012–2016, lung cancer ranks among the top five cancers in women, constituting 6.2% of all cancer cases in females. The age-adjusted incidence rate for lung cancer in women is highest in Aizawl district, Mizoram (27.9 per 100,000), followed by Mizoram state (18.0 per 100,000). Trends show a significant increase in lung cancer incidence in cities like Bengaluru, Chennai, Delhi, and Mumbai from 1982 to 2016. Dr Vishnu Hari, Senior Consultant & Head, Medical Oncology, Haematology & BMT, Sarvodaya Hospital, Sector-8, Faridabad shares all you need to know: Another alarming statistic is that the age-adjusted lung cancer incidence among females in India is increasing annually and approaching that of males. Approximately 32% of lung cancer cases in women occur in the 55–64 age group, and adenocarcinoma is the dominant histological subtype, accounting for 53% of cases in females compared to 34% in males. In a Kolkata-based study, more than 2/3 rd of female lung cancer patients were non-smokers, suggesting that lung cancer is not solely a smoker's disease. Symptoms in females are frequently missed or misdiagnosed, delaying treatment and resulting in poor outcomes. The reasons for neglected symptoms are a mix of biological, sociological, and diagnostic issues specific to women. In India, around half of female lung cancer patients are diagnosed at an advanced stage, which contributes to high mortality rates. More women are diagnosed with lung cancer who are non-smokers than ever before. Research across studies, including NCRP data, confirms that many women diagnosed with lung cancer in India have never smoked. This can lead to a bias where healthcare professionals may overlook lung cancer as a potential cause of symptoms, particularly in young, otherwise healthy women who are non-smokers. Biologically, lung cancer in non-smoker females often presents as adenocarcinoma with a particular mutation in the EGFR gene which is treated differently than a lung cancer without this mutation, whereas smokers more commonly develop other types of cancer viz. squamous cell carcinoma or small cell lung cancer, linked to tobacco-related carcinogens. Environmental factors like air pollution, second hand smoke, and indoor biomass fuel exposure are significant contributors to non-smoker lung cancer in Indian women. The biological differences in lung cancer between non-smokers and smokers have significant treatment implications. Non-smoker females with adenocarcinoma frequently harbor EGFR mutations, making them more responsive to targeted therapies like EGFR tyrosine kinase inhibitors (e.g., gefitinib or erlotinib), which can improve survival compared to traditional chemotherapy. In contrast, smokers with squamous cell carcinoma often lack these mutations and are more likely to benefit from chemotherapy or immunotherapy, due to a higher tumor mutational burdens associated with tobacco exposure. These differences underscore the need for doing additional advanced tests to identify certain genetic mutations, at diagnosis to tailor lung cancer treatment. Frequently observed symptoms such as fatigue, shortness of breath, back pain, or a cough lasting three weeks are often dismissed as non-serious conditions like asthma, allergies, menopause, or anxiety. In India, vague or mild symptoms may be ignored by both healthcare providers and patients, limiting opportunities for timely imaging and testing. Women also tend to present with non-specific symptoms, such as shoulder pain and hoarseness, compared to men. Societal roles and caregiving responsibilities also delay diagnosis. Women in India often prioritize family well-being over personal health, leading to delays in seeking care. This may cause women to dismiss early warning signs or postpone medical consultations until serious symptoms develop. Developing awareness among women and primary healthcare providers is critical. Persistent or unusual respiratory symptoms, even in non-smokers, should prompt immediate investigation with chest X-rays or CT scans. In India, where 75% of lung cancer cases are diagnosed at stages 3 or 4, early detection is vital to improve survival rates. Public health campaigns must emphasize that lung cancer affects women without observable risk factors, including non-smokers. Increasing advocacy for annual check-ups, detailed medical histories, and addressing gender biases in medical diagnoses can reduce delayed or missed diagnoses. For women in India, lung cancer is often in plain sight but overlooked due to diagnostic and societal barriers. Recognizing women-specific symptoms, risk profiles, and the rising incidence (e.g., 30,109 projected cases by 2025) is essential to advocate for early detection and intervention, ultimately improving survival outcomes. The News18 Lifestyle section brings you the latest on health, fashion, travel, food, and culture — with wellness tips, celebrity style, travel inspiration, and recipes. Also Download the News18 App to stay updated! First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
New Indian Express
14 hours ago
- New Indian Express
Committee set up to monitor fertility centres
HYDERABAD: In response to the recent surrogacy racket involving multiple arrests, the Health department on Saturday constituted a committee to inspect all private IVF clinics and fertility centres in the state. The committee, functioning under the supervision of the Health Commissioner, will assess whether these establishments comply with legal, clinical and ethical standards in reproductive medical services. The racket came to light after the arrest of several individuals, including the founder-director of Universal Srushti Fertility Centre, Athaluri Namratha alias Pachipala Namratha, her son Pachipala Jayanth Krishna, centre manager C Kalyani Atchayyamma, Gandhi Hospital anaesthetist Dr Nargula Sadanandam, lab technician Gollamandala Chenna Rao, and agent Dhanasri Santoshi. They have been accused of purchasing babies from vulnerable women and presenting them as children born through surrogacy. In an order issued by Health Secretary Christina Z Chongthu, the department noted that certain IVF clinics were operating in violation of the Assisted Reproductive Technology (Regulation) Act, 2011, and the Surrogacy (Regulation) Act, 2021. Concerns were raised over the lack of mandatory registration, procedural transparency, and breaches of ethical guidelines, particularly regarding gamete donation, embryo transfers and surrogacy arrangements. According to the order, the three-member committee will include the Health Commissioner, the CEO of the Rajiv Aarogyasri Health Care Trust, and the Director of Medical Education. The committee is expected to submit its report to the government within 10 days. It has been authorised to summon any official or expert to provide information relevant to the inquiry.
